MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/110/0.1/20.12.24 | Market Closed - Börse Stuttgart 17:51:12 05/07/2024 BST | ||
| 3.37 EUR | +4.01% |
|
| Current month | -5.34% | ||
| 3 months | +40.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 3.37 | +4.01% |
| 04/07/24 | 3.24 | +5.54% |
| 03/07/24 | 3.07 | -11.01% |
| 02/07/24 | 3.45 | -7.01% |
| 01/07/24 | 3.71 | +4.21% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 05:51 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME1GAR |
| ISIN | DE000ME1GAR8 |
| Date issued | 03/10/2023 |
| Strike | 110 $ |
| Maturity | 20/12/2024 (168 Days) |
| Parity | 10 : 1 |
| Emission price | 0.78 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.81 € |
|---|---|
| Lowest since issue | 0.6 € |
| Delta | 0.87x |
| Omega | 3.342 |
| Premium | 3.34x |
| Gearing | 3.83x |
| Moneyness | 1.294 |
| Difference Strike | -32.37 $ |
| Difference Strike % | -29.43% |
| Spread | 0.01 € |
| Spread % | 0.29% |
| Theoretical value | 3.425 |
| Implied Volatility | 40.33 % |
| Total Loss Probability | 18.94 % |
| Intrinsic value | 2.986 |
| Present value | 0.4389 |
| Break even | 147.13 € |
| Theta | -0.02x |
| Vega | 0.02x |
| Rho | 0.04x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974
DKK
Average target price
952.2
DKK
Spread / Average Target
-2.24%
- Stock Market
- Warrants
- Warrant
